PARP1 and Alzheimer disease: Considering that NAD+ is a balance between its consumption and synthesis, we also examined the transcript levels of genes encoding enzymes that consume or degrade NAD+, such as CD38 and PARP (Supplementary Figure S2), which were also found to be elevated in AD skin (Figure 2D and Figure 3A,C).